183 related articles for article (PubMed ID: 15331928)
21. Overexpression of GLUT3 placental glucose transporter in diabetic rats.
Boileau P; Mrejen C; Girard J; Hauguel-de Mouzon S
J Clin Invest; 1995 Jul; 96(1):309-17. PubMed ID: 7615800
[TBL] [Abstract][Full Text] [Related]
22. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
23. Modulation of expression of glucose transporters GLUT3 and GLUT1 by potassium and N-methyl-D-aspartate in cultured cerebellar granule neurons.
Maher F; Simpson IA
Mol Cell Neurosci; 1994 Aug; 5(4):369-75. PubMed ID: 7804607
[TBL] [Abstract][Full Text] [Related]
24. Comparison of GLUT1, GLUT3, and GLUT4 mRNA and the subcellular distribution of their proteins in normal human muscle.
Stuart CA; Wen G; Gustafson WC; Thompson EA
Metabolism; 2000 Dec; 49(12):1604-9. PubMed ID: 11145124
[TBL] [Abstract][Full Text] [Related]
25. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
26. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues.
Binder C; Binder L; Marx D; Schauer A; Hiddemann W
Anticancer Res; 1997; 17(6D):4299-304. PubMed ID: 9494524
[TBL] [Abstract][Full Text] [Related]
27. Distribution of the glucose transporters in human brain tumors.
Nishioka T; Oda Y; Seino Y; Yamamoto T; Inagaki N; Yano H; Imura H; Shigemoto R; Kikuchi H
Cancer Res; 1992 Jul; 52(14):3972-9. PubMed ID: 1617673
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of the GLUT1 and GLUT3 glucose transporters by growth factors and pro-inflammatory cytokines in equine articular chondrocytes.
Phillips T; Ferraz I; Bell S; Clegg PD; Carter SD; Mobasheri A
Vet J; 2005 Mar; 169(2):216-22. PubMed ID: 15727913
[TBL] [Abstract][Full Text] [Related]
29. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of Glut3 in human tumors and normal tissues.
Younes M; Lechago LV; Somoano JR; Mosharaf M; Lechago J
Anticancer Res; 1997; 17(4A):2747-50. PubMed ID: 9252709
[TBL] [Abstract][Full Text] [Related]
31. [Tissue microarray and in situ hybridization study on hypoxia inducible factor 1alpha mRNA expression in epithelial ovarian tumor].
Luo J; Peng ZL; Wang H; Cheng YF; Yang KX; Xie L; Qian XL; Zou Y
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):168-70. PubMed ID: 12795846
[TBL] [Abstract][Full Text] [Related]
32. Cerebral glucose utilization and glucose transporter expression: response to water deprivation and restoration.
Koehler-Stec EM; Li K; Maher F; Vannucci SJ; Smith CB; Simpson IA
J Cereb Blood Flow Metab; 2000 Jan; 20(1):192-200. PubMed ID: 10616808
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
34. GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.
Serin IS; Tanriverdi F; Ata CD; Akalin H; Ozcelik B; Ozkul Y; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):92-6. PubMed ID: 20018426
[TBL] [Abstract][Full Text] [Related]
35. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
36. Glucose transporters in the human placenta.
Illsley NP
Placenta; 2000 Jan; 21(1):14-22. PubMed ID: 10692246
[TBL] [Abstract][Full Text] [Related]
37. Glucose transporter 1 expression is enhanced during corneal epithelial wound repair.
Takahashi H; Kaminski AE; Zieske JD
Exp Eye Res; 1996 Dec; 63(6):649-59. PubMed ID: 9068372
[TBL] [Abstract][Full Text] [Related]
38. Facilitative glucose transporter expression in human cancer tissue.
Smith TA
Br J Biomed Sci; 1999; 56(4):285-92. PubMed ID: 10795374
[TBL] [Abstract][Full Text] [Related]
39. Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
Younes M; Juarez D; Lechago LV; Lerner SP
Anticancer Res; 2001; 21(1B):575-8. PubMed ID: 11299807
[TBL] [Abstract][Full Text] [Related]
40. Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and corpus luteum.
Nishimoto H; Matsutani R; Yamamoto S; Takahashi T; Hayashi KG; Miyamoto A; Hamano S; Tetsuka M
J Endocrinol; 2006 Jan; 188(1):111-9. PubMed ID: 16394180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
